title: Symptoms after accelerated immunisation.
abstract: OBJECTIVE
  To document the incidence of symptoms after accelerated immunisation with diphtheria-tetanus-pertussis vaccine.
  
  
  METHODS
  Controlled study of children immunised with adsorbed diphtheria-tetanus-pertussis vaccine at accelerated and standard schedules.
  
  
  METHODS
  Colchester and north Hertfordshire.
  
  
  METHODS
  107 children scheduled to receive immunisation at 2, 3, and 4 months of age and 115 children scheduled to receive immunisation at 3, 4 1/2 to 5, and 8 1/2 to 11 months of age.
  
  
  METHODS
  Parentally recorded symptoms, axillary temperatures, and size of local redness and swelling at the injection site during the seven days after immunisation.
  
  
  RESULTS
  In general symptoms occurred less frequently with the accelerated schedule. Proportions of parents reporting axillary temperatures greater than 37.2 degrees C or local redness or swelling greater than 2.5 cm after the third dose of vaccine were significantly reduced in the accelerated schedule group.
  
  
  CONCLUSIONS
  Immunisation at 2, 3, and 4 months of age is likely to cause fewer reactions than immunisation at 3, 4 1/2 to 5, and 8 1/2 to 11 months of age.
authors.affiliation: Immunisation Division, PHLS Communicable Disease Surveillance Centre, London.
authors.forename: M E
authors.initials: ME
authors.lastname: Ramsay
authors.forename: M
authors.initials: M
authors.lastname: Rao
authors.forename: N T
authors.initials: NT
authors.lastname: Begg
mesh_terms: D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage* / Q000009:adverse effects*; D005334:Fever / Q000209:etiology; D006801:Humans; D007114:Immunization / Q000009:adverse effects*; D007115:Immunization Schedule; D007117:Immunization, Secondary / Q000009:adverse effects; D007223:Infant; D007249:Inflammation / Q000209:etiology
chemical_list: D015721:Diphtheria-Tetanus-Pertussis Vaccine